web analytics
Become MergersCorp Agent | Book a Virtual Meeting | FREE BUSINESS VALUATION |
✕

© 2026 MergersCorp M&A International.

© 2025 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities (“Members”) located throughout the world to provide Investment Banking, Corporate Finance, and Advisory Services and other client-related professional services. The Member Firms (“Members”) are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit our Disclaimer: https://mergerscorp.com/disclaimer. MergersCorp M&A International's franchising program is not offered to individuals or entities located in the United States.

 

The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom. 

 

MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.   

 

U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.

Back to Listings
Contact M&A Advisor








    Return to Listings
    1. Home
    2. Manufacturing
    3. Manufacturing - Chemicals Pharma & Life Sciences
    4. Central Asian Chlor-Alkali & Chemicals Manufacturing Platform

    Central Asian Chlor-Alkali & Chemicals Manufacturing Platform

    Description

    Kazakhstan
    L#20261174
    The proposed project entails the development of a state-of-the-art, vertically integrated chlor-alkali and downstream specialty chemical manufacturing cluster in Kazakhstan. Capitalizing on abundant domestic salt reserves, competitive operating fundamentals, and strategic Eurasian logistics corridors, the project is structured to substitute high-volume chemical imports and capture expanding export demand across Central Asia.

    Key Investment Metrics

    Metric Target Value
    Total Capital Expenditure (CapEx) US$1.06 Billion
    Project Net Present Value (NPV) US$62.2 Million
    Internal Rate of Return (IRR) 15.2%
    Simple Payback Period 5.7 Years
    Discounted Payback Period 9.1 Years
    Primary Target Markets Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan, Turkmenistan

    Strategic Value Drivers

    • Upstream Feedstock Security: Kazakhstan produces 1.2–1.9 million tonnes of salt annually (1.85 million tonnes in 2024), anchored by the Kyzylorda region (>70% of national output). This captive, low-cost supply provides a sustainable baseline margin advantage across the chlor-alkali chain.
    • Significant Import-Substitution Market: Central Asia currently imports over US$700 million annually of PVC, caustic soda, and surfactants—a market projected to approach US$1.0 billion by 2030. The cluster directly targets these import flows while servicing structural deficits in local manufacturing and infrastructure.
    • Comprehensive Value-Chain Integration: The project extends basic chlor-alkali capacity into premium, margin-resilient downstream segments:
      • Upstream & Intermediates: Caustic Soda (NaOH), Chlorine (Cl₂), Hydrogen (H₂), Hydrochloric Acid (HCl), Sodium Hypochlorite (NaClO), Hydrogen Peroxide (H₂O₂).
      • Advanced Downstream: Polyvinyl Chloride (PVC), Surfactants, Chlorinated Paraffins, Coagulants, Epoxy Resins, and Formulated Household/Industrial Chemicals.
    • Established Industrial Foundation: Builds upon an operational domestic footprint (producing ~30k t/a caustic soda, ~26k t/a chlorine, ~45k t/a HCl, and ~6.6k t/a NaClO), mitigating brownfield integration and technology adoption risks.
    • Cross-Border Logistical Connectivity: Centrally located along major Eurasian transit corridors, utilizing 11 international transport corridors (6 road, 5 rail) and the Trans-Caspian International Transport Route (Middle Corridor) for cost-effective export into Central Asia, the Caucasus, Türkiye, and Europe.

    Target Investor Profile & Next Steps

    This investment opportunity is structured for:
    • Strategic global chemical producers seeking a cost-advantaged Eurasian production hub
    • Diversified industrial conglomerates and infrastructure investment funds
    • Private equity sponsors focused on basic materials, industrial real assets, and import-substitution platforms
    Line Item Amount (US$ M) % of Revenue Strategic Notes
    Gross Revenue $620.0 100.0% Blended sales: bulk chlor-alkali + premium downstream (PVC, resins, surfactants)
    Raw Materials & Feedstock ($148.8) 24.0% Domestic salt advantage, ethylene/petrochem inputs, catalysts
    Power & Utilities ($161.2) 26.0% Chlor-alkali electrolysis power intensity
    Direct Labor & Plant O&M ($49.6) 8.0% Specialized chemical operators, regular turnaround maintenance
    Logistics & Distribution ($37.2) 6.0% Rail/road freight across Central Asia & Middle Corridor
    Cost of Goods Sold (COGS) ($396.8) 64.0% Total direct manufacturing costs
    Gross Profit $223.2 36.0%
    SG&A and Corporate Overheads ($37.2) 6.0% Commercial team, compliance, licensing, regional distribution offices
    EBITDA $186.0 30.0% ~5.7x CapEx/EBITDA multiple (aligns with 5.7-yr simple payback)
    Depreciation & Amortization (D&A) ($53.0) 8.5% Straight-line asset depreciation (~20-year operational life)
    EBIT (Operating Income) $133.0 21.5%
    Net Financing Costs ($38.0) 6.1% Indicative 60:40 debt-to-equity leverage structure
    Earnings Before Taxes (EBT) $95.0 15.3%
    Corporate Income Tax ($19.0) 3.1% Statutory 20% CIT rate (excl. potential SEZ tax incentives)
    Net Income $76.0 12.3%

     

    1. Informational & Preliminary Nature Only

    This document, its appendices, and any accompanying materials (collectively, the “Materials”) have been prepared solely for preliminary informational and discussion purposes. Nothing contained herein constitutes, or shall be construed as:
    • An offer to sell, or a solicitation of an offer to purchase, any equity, debt, security, asset, or business enterprise.
    • Financial, investment, tax, legal, regulatory, or technical engineering advice.
    • A binding commitment, agreement, or obligation of any kind on the part of the project sponsors, preparers, advisors, or their respective affiliates (collectively, the “Disclosing Parties”).

    2. Forward-Looking Statements & Financial Estimates

    The Materials contain forward-looking statements, including—without limitation—financial forecasts, projected run-rates, Internal Rate of Return (IRR), Net Present Value (NPV), payback periods, Revenue, EBITDA, margins, capital expenditures (CapEx), market growth projections, and operational benchmarks.
    These statements are inherently speculative, based on subjective assumptions, preliminary economic modeling, and current market conditions that are subject to substantial commercial, macroeconomic, geopolitical, and regulatory risks. No representation, warranty, or undertaking—express or implied—is made by the Disclosing Parties that any projection, forecast, target, or estimate will be achieved, realized, or proven accurate. Actual operational, financial, and market results may vary materially from those presented.

    3. No Verification, Accuracy, or Completeness

    The quantitative and qualitative information set forth herein has been compiled from internal estimates and external third-party sources believed to be reliable, but it has not been independently verified, audited, or authenticated. The Disclosing Parties expressly disclaim any and all liability or responsibility for the accuracy, completeness, reasonableness, or currency of the information, calculations, and statements contained within the Materials. The Disclosing Parties undertake no obligation to update, amend, rectify, or supplement these Materials after distribution.

    4. Mandatory Independent Due Diligence

    Any recipient of these Materials (“Recipient”) is solely responsible for conducting its own thorough, independent evaluation and due diligence. Recipients are strongly advised to retain their own independent legal, technical, financial, environmental, and tax advisors before evaluating, negotiating, or executing any transaction. Reliance on this document for any investment, financing, or corporate decision is strictly unauthorized and undertaken at the Recipient’s sole risk.

    5. Exclusion & Limitation of Liability

    To the maximum extent permitted by applicable law, neither the Disclosing Parties nor any of their respective directors, officers, employees, partners, agents, advisors, or representatives shall be liable for any loss, liability, damage, expense, or claim—whether direct, indirect, special, incidental, punitive, or consequential (including, without limitation, loss of business, lost profits, loss of opportunity, or wasted expenditure)—arising out of or in connection with the access, use of, or reliance upon these Materials or any omissions herein, regardless of the legal theory (contract, tort, negligence, strict liability, or otherwise).

    6. Confidentiality & Restrictions on Distribution

    These Materials are strictly confidential and proprietary. They are intended solely for the use of the intended individual or entity to whom they have been directly delivered. Acceptance of these Materials constitutes agreement that the Recipient will not copy, reproduce, extract, modify, disclose, or distribute this document, in whole or in part, to any third party without the prior written consent of the Disclosing Parties.
    Detailed operational, technical, and commercial data rooms, as well as formal bilateral discussions, remain strictly contingent upon the execution of a definitive Non-Disclosure Agreement (NDA) and satisfactory investor qualification.

    Basic Details

    Target Price:

    $ 1,000,000,000

    Gross Revenue

    $620,000,000

    EBITDA

    $186,000,000

    Business ID:

    L#20261174

    Country

    Kazakhstan

    Detail

    Business ID:L#20261174
    Property Type:Manufacturing - Chemicals Pharma & Life Sciences, Manufacturing
    Property Status:For Sale
    Target Price: $ 1,000,000,000
    Gross Revenue:$ 620,000,000
    EBITDA:$ 186,000,000
    Target Price / Revenue:1.61x
    Target Price / EBITDA:5.38x
    Contact M&A Advisor








      Published on September 23, 2026 at 8:25 am. Updated on September 23, 2026 at 8:25 am

      The proposed project entails the development of a state-of-the-art, vertically integrated chlor-alkali and downstream specialty chemical manufacturing cluster in Kazakhstan. Capitalizing on abundant domestic salt reserves, competitive operating fundamentals, and strategic Eurasian logistics corridors, the project is structured to substitute high-volume chemical imports and capture expanding export demand across Central Asia.

      Key Investment Metrics

      Metric Target Value
      Total Capital Expenditure (CapEx) US$1.06 Billion
      Project Net Present Value (NPV) US$62.2 Million
      Internal Rate of Return (IRR) 15.2%
      Simple Payback Period 5.7 Years
      Discounted Payback Period 9.1 Years
      Primary Target Markets Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan, Turkmenistan

      Strategic Value Drivers

      • Upstream Feedstock Security: Kazakhstan produces 1.2–1.9 million tonnes of salt annually (1.85 million tonnes in 2024), anchored by the Kyzylorda region (>70% of national output). This captive, low-cost supply provides a sustainable baseline margin advantage across the chlor-alkali chain.
      • Significant Import-Substitution Market: Central Asia currently imports over US$700 million annually of PVC, caustic soda, and surfactants—a market projected to approach US$1.0 billion by 2030. The cluster directly targets these import flows while servicing structural deficits in local manufacturing and infrastructure.
      • Comprehensive Value-Chain Integration: The project extends basic chlor-alkali capacity into premium, margin-resilient downstream segments:
        • Upstream & Intermediates: Caustic Soda (NaOH), Chlorine (Cl₂), Hydrogen (H₂), Hydrochloric Acid (HCl), Sodium Hypochlorite (NaClO), Hydrogen Peroxide (H₂O₂).
        • Advanced Downstream: Polyvinyl Chloride (PVC), Surfactants, Chlorinated Paraffins, Coagulants, Epoxy Resins, and Formulated Household/Industrial Chemicals.
      • Established Industrial Foundation: Builds upon an operational domestic footprint (producing ~30k t/a caustic soda, ~26k t/a chlorine, ~45k t/a HCl, and ~6.6k t/a NaClO), mitigating brownfield integration and technology adoption risks.
      • Cross-Border Logistical Connectivity: Centrally located along major Eurasian transit corridors, utilizing 11 international transport corridors (6 road, 5 rail) and the Trans-Caspian International Transport Route (Middle Corridor) for cost-effective export into Central Asia, the Caucasus, Türkiye, and Europe.

      Target Investor Profile & Next Steps

      This investment opportunity is structured for:
      • Strategic global chemical producers seeking a cost-advantaged Eurasian production hub
      • Diversified industrial conglomerates and infrastructure investment funds
      • Private equity sponsors focused on basic materials, industrial real assets, and import-substitution platforms
      Line Item Amount (US$ M) % of Revenue Strategic Notes
      Gross Revenue $620.0 100.0% Blended sales: bulk chlor-alkali + premium downstream (PVC, resins, surfactants)
      Raw Materials & Feedstock ($148.8) 24.0% Domestic salt advantage, ethylene/petrochem inputs, catalysts
      Power & Utilities ($161.2) 26.0% Chlor-alkali electrolysis power intensity
      Direct Labor & Plant O&M ($49.6) 8.0% Specialized chemical operators, regular turnaround maintenance
      Logistics & Distribution ($37.2) 6.0% Rail/road freight across Central Asia & Middle Corridor
      Cost of Goods Sold (COGS) ($396.8) 64.0% Total direct manufacturing costs
      Gross Profit $223.2 36.0%
      SG&A and Corporate Overheads ($37.2) 6.0% Commercial team, compliance, licensing, regional distribution offices
      EBITDA $186.0 30.0% ~5.7x CapEx/EBITDA multiple (aligns with 5.7-yr simple payback)
      Depreciation & Amortization (D&A) ($53.0) 8.5% Straight-line asset depreciation (~20-year operational life)
      EBIT (Operating Income) $133.0 21.5%
      Net Financing Costs ($38.0) 6.1% Indicative 60:40 debt-to-equity leverage structure
      Earnings Before Taxes (EBT) $95.0 15.3%
      Corporate Income Tax ($19.0) 3.1% Statutory 20% CIT rate (excl. potential SEZ tax incentives)
      Net Income $76.0 12.3%

       

      1. Informational & Preliminary Nature Only

      This document, its appendices, and any accompanying materials (collectively, the “Materials”) have been prepared solely for preliminary informational and discussion purposes. Nothing contained herein constitutes, or shall be construed as:
      • An offer to sell, or a solicitation of an offer to purchase, any equity, debt, security, asset, or business enterprise.
      • Financial, investment, tax, legal, regulatory, or technical engineering advice.
      • A binding commitment, agreement, or obligation of any kind on the part of the project sponsors, preparers, advisors, or their respective affiliates (collectively, the “Disclosing Parties”).

      2. Forward-Looking Statements & Financial Estimates

      The Materials contain forward-looking statements, including—without limitation—financial forecasts, projected run-rates, Internal Rate of Return (IRR), Net Present Value (NPV), payback periods, Revenue, EBITDA, margins, capital expenditures (CapEx), market growth projections, and operational benchmarks.
      These statements are inherently speculative, based on subjective assumptions, preliminary economic modeling, and current market conditions that are subject to substantial commercial, macroeconomic, geopolitical, and regulatory risks. No representation, warranty, or undertaking—express or implied—is made by the Disclosing Parties that any projection, forecast, target, or estimate will be achieved, realized, or proven accurate. Actual operational, financial, and market results may vary materially from those presented.

      3. No Verification, Accuracy, or Completeness

      The quantitative and qualitative information set forth herein has been compiled from internal estimates and external third-party sources believed to be reliable, but it has not been independently verified, audited, or authenticated. The Disclosing Parties expressly disclaim any and all liability or responsibility for the accuracy, completeness, reasonableness, or currency of the information, calculations, and statements contained within the Materials. The Disclosing Parties undertake no obligation to update, amend, rectify, or supplement these Materials after distribution.

      4. Mandatory Independent Due Diligence

      Any recipient of these Materials (“Recipient”) is solely responsible for conducting its own thorough, independent evaluation and due diligence. Recipients are strongly advised to retain their own independent legal, technical, financial, environmental, and tax advisors before evaluating, negotiating, or executing any transaction. Reliance on this document for any investment, financing, or corporate decision is strictly unauthorized and undertaken at the Recipient’s sole risk.

      5. Exclusion & Limitation of Liability

      To the maximum extent permitted by applicable law, neither the Disclosing Parties nor any of their respective directors, officers, employees, partners, agents, advisors, or representatives shall be liable for any loss, liability, damage, expense, or claim—whether direct, indirect, special, incidental, punitive, or consequential (including, without limitation, loss of business, lost profits, loss of opportunity, or wasted expenditure)—arising out of or in connection with the access, use of, or reliance upon these Materials or any omissions herein, regardless of the legal theory (contract, tort, negligence, strict liability, or otherwise).

      6. Confidentiality & Restrictions on Distribution

      These Materials are strictly confidential and proprietary. They are intended solely for the use of the intended individual or entity to whom they have been directly delivered. Acceptance of these Materials constitutes agreement that the Recipient will not copy, reproduce, extract, modify, disclose, or distribute this document, in whole or in part, to any third party without the prior written consent of the Disclosing Parties.
      Detailed operational, technical, and commercial data rooms, as well as formal bilateral discussions, remain strictly contingent upon the execution of a definitive Non-Disclosure Agreement (NDA) and satisfactory investor qualification.

      MergersCorp M&A
      International As Seen On

      • brand 1
      • brand 1
      • brand 1
      • brand 1
      • brand 1